EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gut microbial metabolites in cutaneous inflammation: shared mechanisms and therapeutic opportunities

Biyu Hu, Lin Du, Danfeng Chu, Erwen Kou, Haixia Zhao, Baiping Dong, Bo Wang, Yuanjie Zhu

Frontiers in Immunology · 14.07.2026 · 17

DOI: 10.3389/fimmu.2026.1850282 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Immunology, online erschienen am 14.07.2026. Verfasst von Biyu Hu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Naval Medical Centre, Naval Medical University, Shanghai, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Skin, Dermatitis, Atopic. Die Arbeit nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cutaneous inflammation is influenced by systemic signals beyond the skin, and gut microbial metabolites contribute to skin homeostasis and inflammatory responses. Major classes of gut-derived metabolites, including short-chain fatty acids, tryptophan-derived compounds, and secondary bile acids, may shape cutaneous inflammation through immune, neural, and endocrine pathways. However, current research remains fragmented across metabolite classes and pathways, and cross-pathway interactions remain unclear. As a result, the relationship between metabolite disturbances and distinct inflammatory phenotypes remains incompletely understood. Atopic dermatitis and chronic spontaneous urticaria are used as representative examples of this variability. This review summarizes major metabolite classes, the pathways linking them to cutaneous inflammation, and current therapeutic strategies targeting these pathways. Therapeutic strategies targeting gut microbial metabolites include direct metabolite supplementation, microbiome-targeted strategies that modify metabolite output, and indirect host-directed interventions. Available evidence suggests that gut microbial metabolites may serve as potential therapeutic targets in cutaneous inflammation. However, current limitations include context-dependent effects, limited causal evidence, variable treatment response, and unresolved issues in delivery and tissue specificity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeSkinDermatitis, AtopicHumansAnimalsInflammation

Stichwörter der Autor:innen

cutaneous inflammationendocrine signalinggut microbial metabolitesgut-skin axisimmune regulationneural signaling

Autor:innen und Institutionen

  • Department of Dermatology, Naval Medical Centre, Naval Medical University, Shanghai, China.
  • Department of Dermatology, The First Affiliated Hospital of Naval Medical University, Shanghai, China.
  • Naval Medical Centre, Naval Medical University, Shanghai, China.

Zitieren

APA

Hu, B., Du, L., Chu, D., Kou, E., Zhao, H., Dong, B., Wang, B., & Zhu, Y. (2026). Gut microbial metabolites in cutaneous inflammation: shared mechanisms and therapeutic opportunities. Frontiers in Immunology, 17. https://doi.org/10.3389/fimmu.2026.1850282

Vancouver

Hu B, Du L, Chu D, Kou E, Zhao H, Dong B, et al. Gut microbial metabolites in cutaneous inflammation: shared mechanisms and therapeutic opportunities. Frontiers in Immunology. 2026;17. doi:10.3389/fimmu.2026.1850282

BibTeX
@article{Hu2026,
  author = {Hu, Biyu and Du, Lin and Chu, Danfeng and Kou, Erwen and Zhao, Haixia and Dong, Baiping and Wang, Bo and Zhu, Yuanjie},
  title = {Gut microbial metabolites in cutaneous inflammation: shared mechanisms and therapeutic opportunities},
  journal = {Frontiers in Immunology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fimmu.2026.1850282}
}
Kostenlos starten →